Risk stratification and multidisciplinary management strategies for pregnancy complicated by pulmonary arterial hypertension: a narrative review
Abstract
Pulmonary arterial hypertension (PAH) complicating pregnancy is a severe condition that poses a significant threat to maternal and foetal health. Despite recent improvements in outcomes for pregnant women with PAH, attributable to continuous updates in diagnostic and treatment strategies and the implementation of multidisciplinary team management, further research is needed on the clinical applicability of risk stratification systems and standardised processes for multidisciplinary management. This article provides a narrative review of the potential impact of pregnancies complicated by PAH on mothers and foetuses, as well as management strategies during pregnancy and childbirth. The aim is to summarise the health risks and management strategies for pregnant women in the preconception, antenatal, and postpartum periods, thereby providing a reference for clinical practice.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.